Variables | Overall(n = 384) | Survivor (n = 342) | Non-survivor (n = 42) | P value |
---|---|---|---|---|
Gender (male, %) | 307 (79.9) | 273 (79.8) | 34 (81.0) | 0.930 |
Age (year) | 56.09 (13.48) | 55.82 (13.46) | 58.26 (13.64) | 0.268 |
BMI (kg/m2) | 25.72 (3.45) | 25.79 (3.46) | 25.13 (3.28) | 0.240 |
Hospitalization days (mean (SD)) | 16.71 (9.44) | 17.79 (9.15) | 7.98 (6.96) |  < 0.001 |
Time of onset (hour) | 34.09 (86.45) | 36.99 (91.17) | 10.45 (6.30) | 0.060 |
LUL SBP (mmHg) | 132.43 (26.36) | 132.98 (25.87) | 128.00 (30.03) | 0.249 |
LUL DBP (mmHg) | 71.15 (17.65) | 71.64 (17.30) | 67.14 (20.13) | 0.119 |
Heart rate (mean (SD)) | 81.61 (19.51) | 81.61 (19.72) | 81.62 (17.96) | 0.997 |
Hypertension history (n, %) | 287 (74.7) | 256 (74.9) | 31 (73.8) | 0.891 |
Dialysis history (n, %) | 8 (2.1) | 5 (1.5) | 3 (7.1) | 0.004 |
Diabetes history (n, %) | 15 (3.9) | 14 (4.1) | 1 (2.4) | 0.906 |
Smoking (n, %) | 141 (36.7) | 121 (35.4) | 20 (47.6) | 0.167 |
Alcohol consumption (n, %) | 95 (24.7) | 83 (24.3) | 12 (28.6) | 0.674 |
Cerebral infarction history (n, %) | 26 (6.8) | 26 (7.6) | 0 (0.0) | 0.127 |
Coronary heart disease (n, %) | 21 (5.5) | 19 (5.6) | 2 (4.8) | 0.311 |
Lower Limb numbness (n, %) | 66 (17.2) | 57 (16.7) | 9 (21.4) | 0.579 |
Preoperative serological results | ||||
 WBC (10^9/L) | 11.60 [8.80, 13.83] | 11.45 [8.70, 13.78] | 12.60 [10.95, 14.80] | 0.045 |
 Neutrophil count (%) | 9.90 [7.40, 12.20] | 9.70 [7.23, 12.10] | 10.55 [8.18, 12.95] | 0.127 |
 Lymphocyte count (%) | 0.90 [0.60, 1.20] | 0.90 [0.60, 1.20] | 0.95 [0.62, 1.10] | 0.710 |
 Monocytes count (%) | 0.60 [0.40, 0.90] | 0.60 [0.40, 0.90] | 0.75 [0.50, 0.90] | 0.109 |
 Eosinophil count (%) | 0.01 [0.00, 0.02] | 0.01 [0.00, 0.02] | 0.00 [0.00, 0.01] | 0.282 |
 Basophil count (%) | 0.01 [0.01, 0.03] | 0.01 [0.01, 0.03] | 0.02 [0.01, 0.03] | 0.324 |
 PLT (10^9/L) | 142.00 [113.00, 186.25] | 141.50 [113.00, 185.75] | 146.00 [117.25, 186.50] | 0.950 |
 BNP (pg/ml) | 58.50 [24.20, 154.00] | 56.20 [24.20, 143.75] | 71.20 [26.55, 189.00] | 0.299 |
 ALT (U/L) | 29.95 [22.00, 51.25] | 29.00 [21.00, 48.75] | 39.00 [27.25, 59.50] | 0.013 |
 LDH (U/L) | 392.50 [269.00, 534.75] | 386.00 [263.25, 518.50] | 472.00 [285.50, 663.50] | 0.030 |
 Total bile acids (umol/L) | 2.00 [1.00, 5.40] | 1.80 [0.90, 4.70] | 3.65 [1.42, 13.23] | 0.002 |
 Adenosine deaminase (U/L) | 10.80 [9.00, 14.20] | 10.80 [8.90, 14.00] | 11.50 [10.38, 19.35] | 0.027 |
 Urea (mmol/L) | 7.00 [5.70, 9.00] | 6.90 [5.70, 9.00] | 8.15 [5.40, 8.80] | 0.704 |
 Creatinine (umol/L) | 81.00 [63.77, 110.88] | 78.05 [62.15, 105.25] | 115.50 [77.18, 193.07] |  < 0.001 |
 Uric acid (umol/L)) | 384.50 [311.00, 463.25] | 376.00 [309.50, 453.75] | 466.50 [360.25, 545.00] | 0.002 |
 TG (mmol/L) | 1.11 [0.77, 1.75] | 1.08 [0.79, 1.64] | 1.25 [0.73, 2.18] | 0.375 |
 Phosphorus (mmol/L)) | 1.12 [0.93, 1.34] | 1.10 [0.91, 1.31] | 1.23 [1.04, 1.55] | 0.010 |
 CRP (mg/L) | 8.10 [4.00, 33.60] | 9.55 [4.10, 34.88] | 7.00 [3.50, 18.05] | 0.064 |
 eGFR (median [IQR]) | 87.75 [60.90, 114.73] | 89.50 [62.00, 114.90] | 69.75 [56.25, 101.30] | 0.022 |
 cTn (ug/L) | 0.02 [0.01, 0.09] | 0.02 [0.01, 0.08] | 0.06 [0.02, 0.18] | 0.011 |
 PT (s) | 12.40 [11.70, 13.60] | 12.40 [11.60, 13.60] | 12.50 [11.93, 13.60] | 0.284 |
 INR (median [IQR]) | 1.09 [1.02, 1.19] | 1.08 [1.02, 1.19] | 1.14 [1.05, 1.21] | 0.072 |
 APTT (s) | 27.50 [25.90, 30.00] | 27.45 [25.90, 29.90] | 28.20 [26.30, 30.70] | 0.259 |
 TT (s) | 18.45 [16.90, 20.25] | 18.30 [16.80, 20.17] | 18.95 [17.72, 20.80] | 0.068 |
 Fibrinogen (g/L) | 2.20 [1.60, 3.00] | 2.20 [1.60, 3.00] | 2.05 [1.50, 2.40] | 0.030 |
 D dimer (mg/L) | 6.30 [3.22, 13.30] | 5.81 [3.01, 12.15] | 9.15 [6.15, 33.13] |  < 0.001 |
 SIRI | 6.97 [4.19, 11.77] | 6.94 [4.06, 11.73] | 7.44 [5.52, 13.41] | 0.189 |
 NLR | 11.60 [7.00, 18.67] | 11.60 [6.89, 18.67] | 11.96 [8.35, 16.59] | 0.605 |
 MLR | 0.75 [0.50, 1.00] | 0.75 [0.50, 1.00] | 0.82 [0.56, 1.07] | 0.390 |
 PLR | 170.00 [122.50, 242.98] | 170.56 [120.21, 243.65] | 169.28 [136.05, 199.00] | 0.807 |
 SII | 1668.22 [1004.35, 2631.52] | 1641.00 [989.40, 2628.30] | 1878.36 [1117.73, 2709.18] | 0.710 |
 Dimer(mg/L) | 7.82 [3.18, 20.76] | 7.28 [2.93, 19.46] | 12.45 [6.35, 46.98] | 0.004 |
 SCI | 27.38 [16.80, 47.48] | 27.85 [16.85, 50.97] | 23.28 [16.24, 32.42] | 0.102 |
Preoperative imaging results | ||||
  False lumen type ( n , %) |  |  |  | 0.304 |
  Thromboembolic | 177 (46.1) | 157 (45.9) | 20 (47.6) |  |
  Patent Flow | 151 (39.3) | 138 (40.4) | 13 (31.0) |  |
  Partially Thromboembolic | 56 (14.6) | 47 (13.7) | 9 (21.4) |  |
 Multiple tears (n, %) | 70 (18.2) | 69 (20.2) | 1 (2.4) | 0.009 |
 Involvement of iliac arteries (n, %) | 97 (25.3) | 85 (24.9) | 12 (28.6) | 0.738 |
 MA in AD (n, %) | 41 (10.7) | 31 (9.1) | 10 (23.8) | 0.008 |
 RA in AD (n, %) | 37 (9.6) | 31 (9.1) | 6 (14.3) | 0.421 |
 FLM SS (n, %) | 42 (10.9) | 36 (10.5) | 6 (14.3) | 0.635 |
 FLM CS (n, %) | 307 (79.9) | 275 (80.4) | 32 (76.2) | 0.660 |
 Pericardial effusion (n, %) | 313 (81.5) | 276 (80.7) | 37 (88.1) | 0.340 |
 Pleural effusion (n, %) | 52 (13.5) | 49 (14.3) | 3 (7.1) | 0.296 |
 Associated aneurysms (n, %) | 89 (23.2) | 78 (22.8) | 11 (26.2) | 0.767 |
 True cavity (cm) | 2.00 [2.00, 3.00] | 2.20 [2.00, 3.00] | 2.00 [2.00, 3.00] | 0.431 |
 Ascending aortic diameter (cm) | 5.00 [4.00, 5.50] | 5.00 [4.00, 5.50] | 5.00 [5.00, 5.50] | 0.051 |
 True cavity total diameter ratio | 0.50 [0.36, 0.63] | 0.50 [0.36, 0.64] | 0.42 [0.36, 0.57] | 0.309 |
 False cavity (cm) | 2.50 [1.50, 3.00] | 2.50 [1.50, 3.00] | 2.80 [2.00, 3.50] | 0.132 |
 True to false cavity ratio (median [IQR]) | 1.00 [0.59, 1.75] | 1.00 [0.60, 1.75] | 0.80 [0.58, 1.52] | 0.383 |
Operation data | ||||
 Stent type ( n , %) |  |  |  | 0.023 |
  No stent | 65 (16.9) | 52 (15.2) | 13 (31.0) |  |
  TAA + DTA Stent | 170 (44.3) | 152 (44.4) | 18 (42.9) |  |
  DTA Stent | 146 (38.0) | 136 (39.8) | 10 (23.8) |  |
 Valve replacement (n, %) | 75 (19.5) | 65 (19.0) | 10 (23.8) | 0.593 |
 Aortic arch replacement ((n, %) | 204 (53.1) | 184 (53.8) | 20 (47.6) | 0.553 |
 CABG (n, %) | 18 (4.7) | 13 (3.8) | 5 (11.9) | 0.050 |
 Surgical duration (min) | 408.57 (102.86) | 405.33 (102.04) | 434.88 (106.90) | 0.079 |
  Extracorporeal bypass mode ( n , %) | 0.040 | |||
  FA + AxArt + SVC/IVC | 196 (51.0) | 180 (52.6) | 16 (38.1) |  |
  FA + SVC/IVC | 120 (31.2) | 99 (28.9) | 21 (50.0) |  |
  AxArt + SVC/IVC | 62 (16.1) | 58 (17.0) | 4 (9.5) |  |
  AscAo + SVC/IVC | 6 (1.6) | 5 (1.5) | 1 (2.4) |  |
 ECPB (min) | 203.97 (61.20) | 201.40 (57.08) | 224.90 (85.99) | 0.019 |
 AXC (min) | 148.23 (46.44) | 147.63 (46.23) | 153.07 (48.40) | 0.474 |
 DHCAT (min) | 29.26 (12.37) | 29.18 (12.47) | 29.93 (11.67) | 0.712 |
 Postoperative CRRT (n, %) | 71 (18.5) | 46 (13.5) | 25 (59.5) |  < 0.001 |
 Total plasma transfusion (*10 ml) | 100.00 [75.00, 155.00] | 100.00 [75.00, 144.38] | 168.75 [108.12, 238.75] |  < 0.001 |
 Cryoprecipitated coagulation factors (IU) | 9.75 [8.00, 13.75] | 9.50 [8.00, 13.00] | 12.12 [8.94, 15.00] | 0.007 |
 Red Blood Cells Suspension (U) | 9.00 [6.00, 13.50] | 8.50 [6.00, 12.50] | 15.50 [9.62, 26.12] |  < 0.001 |
 IMV (hour) | 31.00 [16.75, 76.25] | 25.00 [16.00, 66.00] | 103.50 [56.00, 192.75] |  < 0.001 |
 ICU (hour) | 121.00 [80.50, 182.50] | 114.25 [80.50, 179.38] | 140.75 [86.12, 228.38] | 0.160 |